Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1.03M Buy
147,639
+841
+0.6% +$7.3K ﹤0.01% 2245
2023
Q4
$1.61M Buy
146,798
+20,287
+16% +$199K ﹤0.01% 2029
2023
Q3
$1.39M Sell
126,511
-3,839
-3% -$54.9K ﹤0.01% 2067
2023
Q2
$2.06M Buy
130,350
+58,239
+81% +$678K ﹤0.01% 1895
2023
Q1
$941K Buy
72,111
+2,876
+4% +$23.6K ﹤0.01% 2371
2022
Q4
$754K Buy
69,235
+1,789
+3% +$22K ﹤0.01% 2537
2022
Q3
$1.08M Buy
67,446
+3,665
+6% +$54.1K ﹤0.01% 2276
2022
Q2
$498K Buy
63,781
+690
+1% +$6.49K ﹤0.01% 2836
2022
Q1
$787K Buy
63,091
+12,739
+25% +$179K ﹤0.01% 2689
2021
Q4
$1.2M Buy
+50,352
New +$1.22M ﹤0.01% 3175

Other funds holding ENVX

Credit Suisse's ENVX Position: Q1 2024 in Review

Credit Suisse increased its Enovix (ENVX) stake by 0.57% in Q1 2024, buying an estimated $7.3K and bringing the position to 147,639 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2245.

Credit Suisse first reported a position in ENVX in Q4 2021 and has held it in 10 quarters since. The position peaked at $2.06M in Q2 2023. 265 funds tracked by Wall St. Rank hold ENVX as of Q1 2024.

  • Credit Suisse held 147,639 shares of Enovix worth $1.03M as of Q1 2024.
  • Credit Suisse bought 841 Enovix shares in Q1 2024, an estimated $7.3K.
  • Enovix made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2245 holding.
  • Credit Suisse first reported a position in Enovix in Q4 2021 and has held it in 10 quarters since.
  • Credit Suisse's Enovix position peaked at $2.06M in Q2 2023.
  • 265 funds tracked by Wall St. Rank held Enovix as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.